echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: The baseline clearance of infliximab is related to the need for colectomy in patients with acute severe ulcerative colitis

    Clin Gastroenterology H: The baseline clearance of infliximab is related to the need for colectomy in patients with acute severe ulcerative colitis

    • Last Update: 2021-03-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

    medsci.


    medsci.


     

     

    The researchers collected clinical data from hospitalized ASUC patients who were treated with infliximab.


     

     

    The results of the study showed that among 39 ASUC patients, the median baseline infliximab clearance rate of 6-month patients who required colectomy was higher than that of patients who did not undergo colectomy (0.


     

     

    This study confirms that among patients hospitalized for ASUC, the higher clearance rate of infliximab calculated before the administration of infliximab is associated with a higher rate of colectomy.


    This study confirms that among patients hospitalized for ASUC, the higher clearance rate of infliximab calculated before the administration of infliximab is associated with a higher rate of colectomy.


     

     

    Original source:

    Robert Battat.


    Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.